Freedom Investment Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-74,302
Closed -$1.66M 809
2021
Q4
$1.66M Buy
74,302
+7,449
+11% +$194K 0.12% 217
2021
Q3
$1.85M Sell
66,853
-2,003
-3% -$61K 0.14% 188
2021
Q2
$2.68M Buy
+68,856
New +$2.47M 0.2% 122
2019
Q4
Sell
-8,975
Closed -$418K 673
2019
Q3
$418K Sell
8,975
-44
-0.5% -$2.05K 0.04% 405
2019
Q2
$472K Sell
9,019
-636
-7% -$37.3K 0.04% 376
2019
Q1
$666K Buy
9,655
+1,832
+23% +$123K 0.05% 312
2018
Q4
$467K Sell
7,823
-176
-2% -$15.2K 0.04% 441
2018
Q3
$920K Sell
7,999
-88
-1% -$9.93K 0.06% 343
2018
Q2
$1.02M Buy
8,087
+1,483
+22% +$181K 0.06% 337
2018
Q1
$715K Buy
6,604
+560
+9% +$62K 0.04% 485
2017
Q4
$662K Buy
6,044
+733
+14% +$73.2K 0.03% 513
2017
Q3
$524K Buy
5,311
+882
+20% +$85.5K 0.03% 571
2017
Q2
$449K Buy
4,429
+892
+25% +$96.2K 0.03% 611
2017
Q1
$409K Buy
3,537
+1,412
+66% +$164K 0.02% 622
2016
Q4
$255K Buy
+2,125
New +$235K 0.02% 765

Other funds holding CLB

Freedom Investment Management's CLB Position: Q1 2022 in Review

Freedom Investment Management sold out of Core Laboratories (CLB) in Q1 2022, closing a stake of 74,302 shares — an estimated $1.66M sold.

Freedom Investment Management first reported a position in CLB in Q4 2016 and held it in 15 quarters. The position peaked at $2.68M in Q2 2021. 196 funds tracked by Wall St. Rank hold CLB as of Q1 2022.

  • Freedom Investment Management reported no remaining Core Laboratories position as of Q1 2022 after selling out during the quarter.
  • Freedom Investment Management sold 74,302 Core Laboratories shares in Q1 2022, an estimated $1.66M.
  • Freedom Investment Management first reported a position in Core Laboratories in Q4 2016 and held it in 15 quarters.
  • Freedom Investment Management's Core Laboratories position peaked at $2.68M in Q2 2021.
  • 196 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2022.

Based on Freedom Investment Management's 13F filing for Q1 2022, filed 16 May 2022.